To remain competitive, drug developers must double down on data driven decision making, always-on IP surveillance, rigorous safety validation, and early diversification into new modalities and indications
W.KangL.RabinovitchP
Many of our patients wonder: Does paying more for BPC-157 mean getting a better product
Krinsky NI, Landrum JT, Bone RA
Pelton Shepherd Industries supports pharmaceutical manufacturers and distributors with gel pack solutions tailored to your shipping and regulatory guidelines
Although the aged brain does have increases in ROS, pro-inflammatory cytokines, and a general reduction in glial cell function, the extent of these changes and the dynamics at play are inherently different than those observed after the application of LPS or experimentally-induced demyelination at younger ages